Orient Securities Company (600958) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
1 Nov, 2026Executive summary
2023 operating revenue was RMB17.09bn and net profit RMB2.754bn; revenue and profit declined YoY, while total assets increased 4.24%.
Strategic priorities include transforming the three core business lines, improving business quality and management, and pursuing stable, high-quality development.
Financial highlights
Operating revenue was RMB17.09bn in 2023, down 8.75% YoY; net profit was RMB2.754bn, down 8.53% YoY.
Total assets reached RMB383.69bn at Dec. 31, 2023, up 4.24%; net assets were RMB78.746bn, up 1.76%.
Outlook and guidance
Next-phase priorities are integrated financial services, upgrading the three main business lines, improving business quality, and strengthening core capabilities and management systems.
The operating approach emphasizes customer-, goal-, development- and problem-oriented execution, stronger traditional advantages, and stable, high-quality development.
Latest events from Orient Securities Company
- Nine-month profit rose as Q3 earnings fell sharply; Shanghai Securities deal cleared review.600958
Q3 2026 - Net profit rose 30.48% on 19.48% revenue growth, led by wealth management and a major acquisition.600958
Q2 2026 - Net profit rose 10.55% year-over-year, with trading suspended for a major acquisition.600958
Q1 2026 - 2025 saw robust profit and revenue growth, with digital and international strategies set for 2026.600958
Q4 2025 - Net profit rose 64.02% on 38.87% revenue growth, with strong segment gains and a 29.23% payout.600958
Q2 2025 - Q3 net profit surged 24.58% year-over-year, with a strong mid-year dividend payout.600958
Q3 2024 - Net profit up 11.05% to RMB 2.11bn, driven by wealth management and strong capital metrics.600958
Q2 2024 - Net profit jumped 62.08% in Q1 2025, led by proprietary trading and wealth management.600958
Q1 2025 - Net profit surged 21.68% year-over-year on strong trading income and lower impairments.600958
Q4 2024